Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
Prediabetes (PD) was defined as an state in which glucose levels are above normal but not
enough to meet criteria for the diagnosis of type 2 diabetes (T2D). PD can be presented as
impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and glycated hemoglobin A1c
(A1C) altered. The International Diabetes Federation (IDF) reported that in 2013 the
prevalence of IGT was 6.9% which is equivalent to approximately 316 million individuals with
IGT, it is expected that by 2035 this number will increase to 417 million people affected.
Many hypoglycemic effects attributed to Gymnema sylvestre have been reported, including:
increase of insulin secretion, regeneration of pancreatic islet cells, increased glucose
utilization in various ways and inhibition of glucose uptake in the intestine.